Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

National Healthcare Properties (NHPBP) EBITDA Margin (2016 - 2025)

National Healthcare Properties has reported EBITDA Margin over the past 13 years, most recently at 33.07% for Q4 2025.

  • For Q4 2025, EBITDA Margin fell 1244.0% year-over-year to 33.07%; the TTM value through Dec 2025 reached 23.99%, up 3546.0%, while the annual FY2025 figure was 23.99%, 3546.0% up from the prior year.
  • EBITDA Margin for Q4 2025 was 33.07% at National Healthcare Properties, down from 20.65% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 4.33% in Q1 2021 and troughed at 136.45% in Q2 2024.
  • A 5-year average of 29.03% and a median of 21.28% in 2021 define the central range for EBITDA Margin.
  • Biggest five-year swings in EBITDA Margin: plummeted -11869bps in 2024 and later skyrocketed 10552bps in 2025.
  • Year by year, EBITDA Margin stood at 17.66% in 2021, then crashed by -62bps to 28.57% in 2022, then crashed by -62bps to 46.26% in 2023, then surged by 55bps to 20.63% in 2024, then crashed by -60bps to 33.07% in 2025.
  • Business Quant data shows EBITDA Margin for NHPBP at 33.07% in Q4 2025, 20.65% in Q3 2025, and 30.93% in Q2 2025.